share_log

同源康醫藥-B:董事會會議日期

TYK MEDICINES-B: DATE OF BOARD MEETING

HKEX ·  Mar 17 08:33

Summary by Moomoo AI

同源康醫藥宣佈,將於2025年3月27日(星期四)召開董事會會議,主要議程包括審議及批准2024年度全年業績報告及其刊發事宜,同時將考慮派發末期股息事項。公司董事會現由董事長兼總裁吳豫生博士領導,成員包括2名執行董事、5名非執行董事及4名獨立非執行董事。
同源康醫藥宣佈,將於2025年3月27日(星期四)召開董事會會議,主要議程包括審議及批准2024年度全年業績報告及其刊發事宜,同時將考慮派發末期股息事項。公司董事會現由董事長兼總裁吳豫生博士領導,成員包括2名執行董事、5名非執行董事及4名獨立非執行董事。
Tongyuan Kang Pharmaceutical announced that a Board of Directors meeting will be held on Thursday, March 27, 2025, with the main agenda including the review and approval of the 2024 annual performance report and its publication, as well as considering the distribution of the final dividend. The company's Board of Directors is currently led by Dr. Wu Yusheng, Chairman and President, and consists of 2 executive directors, 5 non-executive directors, and 4 independent non-executive directors.
Tongyuan Kang Pharmaceutical announced that a Board of Directors meeting will be held on Thursday, March 27, 2025, with the main agenda including the review and approval of the 2024 annual performance report and its publication, as well as considering the distribution of the final dividend. The company's Board of Directors is currently led by Dr. Wu Yusheng, Chairman and President, and consists of 2 executive directors, 5 non-executive directors, and 4 independent non-executive directors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 246

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.